Insulet | PODD - Operating Profit

Stock Price
241.89
Daily Change
-7.21 -2.89%
Monthly
-15.11%
Yearly
-14.47%
Q1 Forecast
234.39

Insulet reported $146.3M in Operating Profit for its fiscal quarter ending in December of 2025.





Operating Profit Change Date
Abbott USD 2.25B 73M Dec/2025
Align Technology USD 224.71M 40.06M Dec/2025
AtriCure USD 2.49M 2.28M Dec/2025
Avanos Medical USD 18.97M 72.63M Sep/2025
Baxter International USD -214.2M 415.4M Dec/2025
Becton, Dickinson and Co. USD 663M 163M Dec/2025
Boston Scientific USD 1.24B 203M Dec/2025
Cardinal Health USD 763M 9M Dec/2025
Cooper Companies USD 140.4M 35.3M Sep/2025
Dexcom USD 323M 80.5M Dec/2025
Edwards Lifesciences USD 370.3M 54.8M Dec/2025
Eli Lilly USD 8.99B 599.9M Dec/2025
Globus Medical USD -117.52M 8.43M Sep/2025
ICU Medical USD 26.09M 770K Dec/2025
Inogen USD -7.79M 728K Sep/2024
Insulet USD 146.3M 28.6M Dec/2025
Integra LifeSciences USD 11.76M 13.07M Sep/2025
J&J USD 5.59B 1.81B Dec/2025
Masimo USD 83.6M 19.1M Sep/2025
Medtronic USD 1.74B 40M Dec/2025
Merit Medical Systems USD 42.61M 4.41M Sep/2025
Roche Holding CHF 9.56B 3.8B Dec/2025
Solventum Corp USD 1.69B 1.47B Sep/2025
Stryker USD 1.97B 609M Dec/2025
Tandem Diabetes Care USD 8.29M 31.16M Dec/2025
Teleflex USD -408.9M 586.38M Sep/2025
West Pharmaceutical Services USD 162.5M 5.1M Dec/2025
Zimmer Biomet Holdings USD 302.9M 35.4M Dec/2025